[1]

Buchhalter AR, Fant RV, Henningfield JE. 2008. Novel Pharmacological Approaches for Treating Tobacco Dependence and Withdrawal. Drugs 68(8):1067

doi: 10.2165/00003495-200868080-00005
[2]

London SJ, Idle JR, Daly AK, CoetzeeGA. 1999. Genetic variation of CYP2A6, smoking, and risk of cancer. Lancet 353(9156):898

doi: 10.1016/s0140-6736(98)04984-8
[3]

Wang J, Li MD. 2010. Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation. Neuropsychopharmacology 35(3):702−9

doi: 10.1038/npp.2009.178
[4]

Li X, Semenova S, D'Souza MS, Stoker AK, Markou A. 2014. Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation. Neuropharmacology 76:554−65

doi: 10.1016/j.neuropharm.2013.05.042
[5]

Pehrson AL, Sanchez C. 2014. Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction. CNS Spectrums 19(2):121−33

doi: 10.1017/s1092852913000540
[6]

Ali DN, Ali HM, Lopez MR, Kang S, Choi DS. 2024. Astrocytic GABAergic regulation in alcohol use and major depressive disorders. Cells 13(4):318

doi: 10.3390/cells13040318
[7]

Jones SK, Wolf BJ, Froeliger B, Wallace K, Carpenter MJ, et al. 2022. Nicotine metabolism predicted by CYP2A6 genotypes in relation to smoking cessation: a systematic review. Nicotine & Tobacco Research 24(5):633−42

doi: 10.1093/ntr/ntab175
[8]

Wu X, Tian Y, Wang H, Chen H, Hou H, et al. 2024. Dual regulation of nicotine on NLRP3 inflammasome in macrophages with the involvement of lysosomal destabilization, ROS and α7nAChR. Inflammation 48:61−74

doi: 10.1007/s10753-024-02036-z
[9]

Chivero ET, Dagur RS, Peeples ES, Sil S, Liao K, et al. 2021. Biogenesis, physiological functions and potential applications of extracellular vesicles in substance use disorders. Cellular and Molecular Life Sciences 78(11):4849−65

doi: 10.1007/s00018-021-03824-8
[10]

McGranahan TM, Patzlaff NE, Grady SR, Heinemann SF, Booker TK. 2011. α4β2 Nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief. Journal of Neuroscience 31(30):10891−902

doi: 10.1523/jneurosci.0937-11.2011
[11]

Sun Y, Xie A, Fang Y, Chen H, Li L, et al. 2024. Altered insular functional activity among electronic cigarettes users with nicotine dependence. Translational Psychiatry 14:293

doi: 10.1038/s41398-024-03007-6